2,4-dichloro-5-sulfobenzoic acid

Brivaracetam impurity 1

Brivaracetam impurity 20

Canagliflozin Alpha Impurity

4-(2-((1E,3E,5E,7E)-7-(3-(4-(methoxysulfonyl)butyl)-1,1-dimethyl-1H-benzo[e]indol-2(3H)-ylidene)hepta-1,3,5-trien-1-yl)-1,1-dimethyl-1H-benzo[e]indol-3-ium-3-yl)butane-1-sulfonate

4-(1,1-dimethyl-2-oxo-1H-benzo[e]indol-3(2H)-yl)butane-1-sulfonic acid

N-(2-nitophentlethyl) acetamide

(Z)-2-fluoro-5-((3-oxoisobenzofuran-1(3H)-ylidene)methyl)benzoic acid

3-(dibutylamino)-4-phenoxy-5-sulfamoylbenzoic acid

(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-4-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

1-(2-methyl-5-nitro-1H-imidazol-1-yl)-3-morpholinopropan-2-ol

2-[(Z)-2-{3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl}-1-hydrazinylethenyl]benzoic acid: [Intermediate] ( Impurity B)

Brivaracetam impurity 226

(S)-2-(oxiran-2-yl)ethanol

2-Naphthylhydrazine

1H-Inden-1-one, 3-amino-2,3-dihydro-, hydrochloride (1:1)

2-[4-(4-Hydroxybenzoyl)phenoxy]-2-methylpropanoic acid

5-Bromo-4-chloro-N-cyclopentyl-2-pyrimidinamine

2-[3-[4-(4-Chlorophenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one

(R)-3-((3-fluoro-4-(6-(2-methyl-2H- tetrazol-5-yl)pyridin-3-yl)phenyl)amino)-2- hydroxypropyl dihydrogen phosphate